The following data is part of a premarket notification filed by Apex Biotechnology Corp. with the FDA for Gal-1a Plus Blood Glucose Monitoring System.
Device ID | K213887 |
510k Number | K213887 |
Device Name: | GAL-1A Plus Blood Glucose Monitoring System |
Classification | System, Test, Blood Glucose, Over The Counter |
Applicant | Apex BioTechnology Corp. No. 7, Li-Hsin Road V, Hsinchu Science Park Hsinchu, CN 30078 |
Contact | Lisa Liu |
Correspondent | Lisa Liu Apex BioTechnology Corp. No. 7, Li-Hsin Road V, Hsinchu Science Park Hsinchu, CN 30078 |
Product Code | NBW |
CFR Regulation Number | 862.1345 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Special |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2021-12-13 |
Decision Date | 2022-03-29 |